News
1d
Pharmaceutical Technology on MSNRegeneron to deploy Telesis Bio’s Gibson SOLA at R&D facilitiesThe strategic move is aimed at integrating automated, high-throughput gene synthesis into Regeneron's in-house laboratories.
Shares of biotech company Regeneron (NASDAQ ... fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
Automation and real-time strategy game Oddsparks: An Automation Adventure will leave Early Access and launch for PlayStation 5, Xbox Series, and PC via Steam and Epic Games Store on May 27 ...
$3 billion FUJIFILM deal will nearly double Regeneron’s large-scale U.S. biologics manufacturing capacity over the next decade. Regeneron adds 7,000+ U.S. jobs in five years, with $7B+ in ...
RPA Robotic process automation innovation technology concept. Wireframe hand turning a knob and selecting RPA mode. Intelligent system automation. AI. Artificial intelligence. Vector illustration The ...
Automation tools have become the unsung heroes of modern productivity, quietly working behind the scenes to simplify our lives and businesses. But with so many options out there, how do you choose ...
NEW YORK, Jan 13 (Reuters) - Medical data research company Truveta said on Monday that Regeneron Pharmaceuticals (REGN.O), opens new tab, Illumina (ILMN.O), opens new ...
Sue Williams, managing director at Hexagon Consultants, shares her insights on overlooked supply chain risks, digital transformation pitfalls, AI’s… Resources Tariffs will have a major impact on your ...
Regeneron Pharmaceuticals, Inc.'s stock has dropped 30% since July due to concerns around Eylea's declining market share in the face of competition from generics and Roche's Vabysmo. Dupixent's ...
Regeneron Pharmaceuticals (NASDAQ:REGN) dropped 4.6% after a judge denied the company's motion for a preliminary injunction to block an Amgen (AMGN) biosimilar version of Regeneron's blockbuster ...
Regeneron showcases robust product sales growth amidst competitive pharmaceutical landscape. Strategic collaborations bolster Regeneron's R&D, presenting both opportunities and financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results